Mackenzie Financial Corp Novo Cure LTD Transaction History

Mackenzie Financial Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$60.15 - $84.52 $726,491 - $1.02 Million	-12,078 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$75.08 - $121.99 $346,869 - $563,593	4,620 Added 61.95%	12,078 $907,000
Q3 2021 Nov 08, 2021	BUY	$116.17 - $194.55 $381,269 - $638,513	3,282 Added 78.59%	7,458 $866,000
Q2 2021 Aug 11, 2021	BUY	$130.4 - $225.58 $544,550 - $942,022	4,176 New	4,176 $926,000
Q2 2018 Aug 13, 2018	SELL	$19.85 - $32.0 $468,460 - $755,200	-23,600 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$19.3 - $23.65 $455,480 - $558,140	23,600 New	23,600 $514,000

263

77M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $3.23B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Mackenzie Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Mackenzie Financial Corp with notifications on news.